Director, Search & Evalutation (West), Novo Nordisk
Tari Suprapto, Ph.D., RTTP is a seasoned technology commercialization professional in the life sciences. She is currently the Director for Search & Evaluation for Western US and Canada for Novo Nordisk, and previously was part of the External Innovation team at Elanco. Tari spent over 15 years commercializing innovations from world-class research institutions such as the Salk Institute, The Rockefeller University, and Memorial Sloan-Kettering Cancer Center. Tari has extensive experience in licensing, building and managing strategic alliances, and a strong scientific background in a variety of therapeutic areas evidenced by her Ph.D. in cell biology from The Rockefeller University and an Honors B.A. from Swarthmore College. Tari is also a member of BIOCOM’s Capital Development Committee and serves on the Board of the Association for University Technology Managers, the San Diego Innovation Council, and official advisor to Founders Corner Venture Capital in San Diego.